MSG-15: Super-Bioavailability Itraconazole Versus Conventional Itraconazole in the Treatment of Endemic Mycoses—A Multicenter, Open-Label, Randomized Comparative Trial
Book •
Mentioned by
Mentioned in 0 episodes
Mentioned by ![undefined]()

; a study comparing suba-itraconazole and conventional itraconazole for endemic mycoses.

Megan Klatt

#109 – IDWeek 2024 Recap: Practice Changing Papers and ID Potpourri